Literature DB >> 25187916

[Does hypofrantionated radiotherapy for breast cancer increase cardiac mortality within 20 years?].

Juliane Rieber, Klaus Herfarth.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25187916     DOI： 10.1007/s00066-014-0684-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Authors:  Rajiv K Agrawal; Abdulla Alhasso; Peter J Barrett-Lee; Judith M Bliss; Peter Bliss; David Bloomfield; Joanna Bowen; A Murray Brunt; Ellen Donovan; Marie Emson; Andrew Goodman; Adrian Harnett; Joanne S Haviland; Ronald Kaggwa; James P Morden; Anne Robinson; Sandra Simmons; Alan Stewart; Mark A Sydenham; Isabel Syndikus; Jean Tremlett; Yat Tsang; Duncan Wheatley; Karen Venables; John R Yarnold
Journal:  Radiother Oncol       Date:  2011-07       Impact factor: 6.280

2.  Distribution of coronary artery stenosis after radiation for breast cancer.

Authors:  Greger Nilsson; Lars Holmberg; Hans Garmo; Olov Duvernoy; Iwar Sjögren; Bo Lagerqvist; Carl Blomqvist
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

3.  Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer.

Authors:  Kristin Holm Tjessem; Safora Johansen; Eirik Malinen; Kristin V Reinertsen; Turi Danielsen; Sophie D Fosså; Alexander Fosså
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-23       Impact factor: 7.038

4.  Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.

Authors:  Sarah C Darby; Paul McGale; Carolyn W Taylor; Richard Peto
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

Review 5.  Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

Authors:  Benjamin D Smith; Soren M Bentzen; Candace R Correa; Carol A Hahn; Patricia H Hardenbergh; Geoffrey S Ibbott; Beryl McCormick; Julie R McQueen; Lori J Pierce; Simon N Powell; Abram Recht; Alphonse G Taghian; Frank A Vicini; Julia R White; Bruce G Haffty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

6.  Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer.

Authors:  Wilson Marhin; Elaine Wai; Scott Tyldesley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-07-02       Impact factor: 7.038

7.  Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Authors:  Maartje J Hooning; Akke Botma; Berthe M P Aleman; Margreet H A Baaijens; Harry Bartelink; Jan G M Klijn; Carolyn W Taylor; Flora E van Leeuwen
Journal:  J Natl Cancer Inst       Date:  2007-03-07       Impact factor: 13.506

8.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.